Here we show that the Pcyt2 + /- NASH liver is heavily differentially methylated, and that PEA exhibits a dramatic reversal of the aberrant methylation underlying the phenotypic improvements in Pcyt2 + /- NASH. Here, PCYT2 is linked to metabolic dysfunction-associated steatohepatitis.